Cliff Asness’s Cabaletta Bio CABA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$155K Buy
+80,840
New +$228K ﹤0.01% 3929
2025
Q3
– Sell
-32,129
Closed -$48.8K – 3481
2025
Q2
$48.8K Sell
32,129
-41,827
-57% -$65.2K ﹤0.01% 3239
2025
Q1
$102K Buy
+73,956
New +$158K ﹤0.01% 3012
2024
Q2
– Sell
-12,311
Closed -$210K – 2610
2024
Q1
$210K Sell
12,311
-1,450
-11% -$31.1K ﹤0.01% 2243
2023
Q4
$312K Sell
13,761
-785
-5% -$13.2K ﹤0.01% 2051
2023
Q3
$221K Buy
+14,546
New +$199K ﹤0.01% 2113

Other funds holding CABA

Cliff Asness's CABA Position: Q3 2026 in Review

Cliff Asness opened a new position in Cabaletta Bio (CABA) in Q3 2026: 80,840 shares worth $155K. The stake represents ﹤0.01% of the portfolio and ranks #3929 among its holdings. This is a return to the name: Cliff Asness previously reported a position in CABA as recently as Q2 2025.

Cliff Asness first reported a position in CABA in Q3 2023 and has held it in 6 quarters since. The position peaked at $312K in Q4 2023. 163 funds tracked by Wall St. Rank hold CABA as of Q3 2026.

  • Cliff Asness held 80,840 shares of Cabaletta Bio worth $155K as of Q3 2026.
  • Cabaletta Bio was a new Cliff Asness position in Q3 2026.
  • Cabaletta Bio made up ﹤0.01% of Cliff Asness's portfolio in Q3 2026, its #3929 holding.
  • Cliff Asness first reported a position in Cabaletta Bio in Q3 2023 and has held it in 6 quarters since.
  • Cliff Asness's Cabaletta Bio position peaked at $312K in Q4 2023.
  • 163 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2026.

Based on AQR Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.